persistent threat of embolization and potential frustration of the prosthetic valve with a beating heart after clamp removal.
Mechanical valve obstruction caused by an occlusion device
Ofer Merin, MD, Dani Bitran, MD, Daniel Fink, MD, Esther Asher, MA, and Shuli Silberman, MD, Jerusalem, Israel M echanical occlusion devices are used mainly for the closure of septal defects or patent ductus. There have been some reports of their use for the closure of paravalvular leaks after valve replacement. The potential for leaflet obstruction of a mechanical mitral prosthesis has so far been unrecognized. This is the first report of this potential complication.
Clinical Summary
A 74-year-old woman underwent coronary bypass and aortic valve replacement with a mechanical device 13 years ago. Two years before the current admission, she underwent a second operation to replace her mitral valve because of heart failure secondary to severe mitral incompetence. Her valve was replaced with a St Jude 25-mm valve (St Jude Medical, St Paul, Minn). Shortly thereafter, shortness of breath developed in the patient, and a severe paravalvular leak was seen on the mitral prosthesis. She then underwent attempted closure of the paravalvular leak with percutaneous insertion of an Amplatzer occlusion device (AGA Medical Corporation, Golden Valley, Minn). Her condition continued to deteriorate, hemolytic anemia developed, and severe mitral regurgitation persisted (seen on echocardiography as an eccentric jet). Fluoroscopy ( Figure 1 ) showed that 1 of the valve leaflets, adjacent to the device, was immobile. She was then referred to our department for repeat mitral valve replacement. The occlusion device was found to impinge on the posterior leaflet, restricting it in a closed position (Figure 2 ). The mitral valve was replaced with a bioprosthesis. The operation and immediate postoperative course were uneventful; however, on the day after surgery massive bleeding developed from the mediastinal drains. Emergency exploration was undertaken in the intensive care unit, which revealed bleeding from the area of the inferoposterior left ventricular wall, suggestive of atrioventricular rupture. The patient could not be resuscitated, and she died. Reexamination of the angiogram revealed a relatively large distance between the original mitral prosthesis and the calcified mitral annulus. This indicates that atrioventricular disruption may have been present before surgery but was contained because of adhesions; however, we could not be certain that the device directly contributed to the catastrophic event.
Discussion
Percutaneous insertion of occluding devices is used mainly for closure of intracardiac defects. Transcatheter closure of paravalvular leaks was first reported by Hourihan and colleagues 1 in 1992. There have been other reports of the use of occlusion devices in the mitral position 2 and aortic position. 3 Pate and colleagues 4 summarized the techniques and considerations of percutaneous device use for closure of prosthetic valve leaks. In their article they mention a number of potential device-related complications, such as valve dehiscence, device embolization, infection, wire trauma, valve leaflet damage, impingement of valve leaflet motion, and hemolysis. Hussain and colleagues 5 reported a case of attempted repair of paravalvular prosthetic mitral leak with an Amplatzer device (AGA Medical Corporation). The patient continued to demonstrate congestive heart failure and hemolysis secondary to persistent paravalvular leak and required surgery to remove the old prosthesis and the device.
Our patient presented with severe congestive heart failure and hemolysis. The intention of avoiding surgery was not realized. Furthermore, she underwent surgery in a compromised clinical state. Current devices are not geometrically adapted to the anatomy of paravalvular leaks. A device may successfully repair a small leak but also propagate valve dehiscence. We believe that paravalvular leaks are best treated with reoperation. At this time, the use of percutaneous occlusion devices for closure of paravalvular leaks should be limited to those patients who are not surgical candidates. To our knowledge, our case is the first report of a device impinging on the valve leaflet. 
